1. Home
  2. MEC vs ARVN Comparison

MEC vs ARVN Comparison

Compare MEC & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$19.11

Market Cap

527.1M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.57

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
ARVN
Founded
1945
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
527.1M
600.2M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
MEC
ARVN
Price
$19.11
$8.57
Analyst Decision
Strong Buy
Buy
Analyst Count
3
19
Target Price
$24.33
$15.05
AVG Volume (30 Days)
448.1K
547.9K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
1.70
Revenue
N/A
$262,600,000.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
N/A
P/E Ratio
N/A
$5.15
Revenue Growth
N/A
N/A
52 Week Low
$12.25
$6.97
52 Week High
$38.76
$14.22

Technical Indicators

Market Signals
Indicator
MEC
ARVN
Relative Strength Index (RSI) 26.26 44.25
Support Level $17.20 $8.37
Resistance Level $19.42 $8.90
Average True Range (ATR) 0.99 0.32
MACD 0.17 -0.10
Stochastic Oscillator 2.39 18.90

Price Performance

Historical Comparison
MEC
ARVN

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: